社債の発行による収入、Transfers To Other Comprehensive Income Related To Assets Held For SaleIFRS、のれん償却額 - 医薬品他1件
- 【期間】
| 年度 | 社債の発行による収入 | Transfers To Other Comprehensive Income Related To Assets Held For SaleIFRS | のれん償却額 - 医薬品 | その他の金融負債 |
|---|
| 2008/03 | - | | - | | - | | - | |
| 2009/03 | - | | - | | - | | - | |
| 2010/03 | - | | - | | - | | - | |
| 2011/03 | - | | - | | - | | - | |
| 2012/03 | - | | - | | - | | - | |
| 2013/03 | - | | - | | 37.7億 | | - | |
| 2014/03 | - | | - | | 50.5億 | +34% | - | |
| 2015/03 | - | | - | | 54.5億 | +7.8% | - | |
| 2016/03 | - | | - | | 59.8億 | +9.8% | - | |
| 2017/03 | - | | - | | 55.6億 | -7% | - | |
| 2018/03 | 398億 | | - | | - | | 522億 | |
| 2019/03 | 497億 | +25% | - | | - | | 507億 | -2.9% |
| 2020/03 | 2826億 | +468.3% | - | | - | | 488億 | -3.9% |
| 2021/03 | 1587億 | -43.8% | - | | - | | 559億 | +14.6% |
| 2022/03 | 348億 | -78.1% | - | | - | | 841億 | +50.5% |
| 2023/03 | - | | - | | - | | 749億 | -10.9% |
| 2024/03 | 398億 | +14.4% | - | | - | | 776億 | +3.6% |
